BR9811473A - Infecção por rinovìrus inibida por óxido nìtrico - Google Patents

Infecção por rinovìrus inibida por óxido nìtrico

Info

Publication number
BR9811473A
BR9811473A BR9811473-5A BR9811473A BR9811473A BR 9811473 A BR9811473 A BR 9811473A BR 9811473 A BR9811473 A BR 9811473A BR 9811473 A BR9811473 A BR 9811473A
Authority
BR
Brazil
Prior art keywords
nitric oxide
inhibited
synthesis
inhibit
infection inhibited
Prior art date
Application number
BR9811473-5A
Other languages
English (en)
Inventor
Scherer P Sanders
David Proud
Original Assignee
Univ Johns Hopkins Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins Med filed Critical Univ Johns Hopkins Med
Publication of BR9811473A publication Critical patent/BR9811473A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"INFECçãO POR RINOVìRUS INIBIDA POR óXIDO NìTRICO".óxido Nítrico gerando compostos ou compostos que produzem insitu síntese de óxido nítrico podem ser usado para inibir infecçãopor rinovírus. O óxido nítrico produz a capacidade para inibir tantoa replicação viral quanto a sintese de citocinas em particular ascitocinas pró-inflamatórias. Assim os sintomas das infecções porrinovírus podem ser aperfeiçoados por tratamentos com oacréscimo de óxido nítrico no tratamento respiratório.
BR9811473-5A 1997-07-11 1998-07-10 Infecção por rinovìrus inibida por óxido nìtrico BR9811473A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5230797P 1997-07-11 1997-07-11
PCT/US1998/014466 WO1999002148A1 (en) 1997-07-11 1998-07-10 Nitric oxide inhibits rhinovirus infection

Publications (1)

Publication Number Publication Date
BR9811473A true BR9811473A (pt) 2001-12-26

Family

ID=21976738

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811473-5A BR9811473A (pt) 1997-07-11 1998-07-10 Infecção por rinovìrus inibida por óxido nìtrico

Country Status (14)

Country Link
US (1) US6277891B1 (pt)
EP (1) EP1011657A1 (pt)
JP (1) JP2001509481A (pt)
KR (1) KR20010021749A (pt)
CN (1) CN1277552A (pt)
AU (1) AU8399098A (pt)
BR (1) BR9811473A (pt)
CA (1) CA2303430A1 (pt)
CZ (1) CZ200092A3 (pt)
HU (1) HUP0002859A2 (pt)
ID (1) ID23780A (pt)
NO (1) NO20000151L (pt)
TR (1) TR200000157T2 (pt)
WO (1) WO1999002148A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030753A1 (es) * 2000-09-25 2003-09-03 Smithkline Beecham Corp Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
DE10303196A1 (de) * 2003-01-28 2004-08-12 Märtz, Hans Helmut Verwendung von Erzeugnissen, Stoffen oder Stoffgemischen, aus welchen im menschlichen oder tierischen Körper Stickoxid (Formel: NO) entsteht, zur Behandlung oder Prophylaxe von Infektionskrankheiten des menschlichen oder tierischen Körpers
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
AU2004255268B2 (en) 2003-07-09 2010-04-01 Loma Linda University Use of nitrite salts for the treatment of cardiovascular conditions
US8252591B2 (en) * 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US8557300B2 (en) 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
EP2188367A4 (en) 2007-08-10 2010-10-27 Whitehead Biomedical Inst HORMONE REACTIVE TISSUE CULTURE SYSTEM, AND USES THEREOF
EP2237788A4 (en) * 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
JP5558458B2 (ja) * 2008-03-20 2014-07-23 タノメド・アクチボラゲット 普通感冒の治療用の医薬の製造における物質の使用
US11850283B2 (en) * 2017-06-27 2023-12-26 Ohio State Innovation Foundation Liponucleotide-based therapy for asthma
CN109432122A (zh) * 2018-11-19 2019-03-08 罗辉 No或no供体在制备预防和/或治疗皮肤疾病或黏膜疾病药物中的应用及药物组合物
CN109846113A (zh) * 2018-11-29 2019-06-07 南京诺全生物医疗科技有限公司 一种可自提供一氧化氮的口鼻卫生用品

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455279A (en) * 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine

Also Published As

Publication number Publication date
KR20010021749A (ko) 2001-03-15
WO1999002148A1 (en) 1999-01-21
CZ200092A3 (en) 2001-05-16
ID23780A (id) 2000-05-11
HUP0002859A2 (hu) 2001-01-29
TR200000157T2 (tr) 2001-06-21
EP1011657A1 (en) 2000-06-28
AU8399098A (en) 1999-02-08
US6277891B1 (en) 2001-08-21
CA2303430A1 (en) 1999-01-21
JP2001509481A (ja) 2001-07-24
NO20000151D0 (no) 2000-01-11
NO20000151L (no) 2000-03-09
CN1277552A (zh) 2000-12-20

Similar Documents

Publication Publication Date Title
BR9811473A (pt) Infecção por rinovìrus inibida por óxido nìtrico
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
DK0678023T3 (da) Anvendelse af riluzol ved fremstilling af lægemidler til behandling af Parkinsons sygdom og parkinsonisme-syndromer
AU4722785A (en) Initiating reperfusion treatment when heart attack symptoms are present
ATE184912T1 (de) Kontinuierliche zellinie sowie impfstoff gegen geflügelinfektion mit kokkidien
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3&#39;-desoxitimidin-2&#39;-eno-(3&#39;-desoxi-2&#39;,3&#39;-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
PT1261333E (pt) Utilizacao de topiramato para o tratamento e diagnostico de transtorno do sono relacionado com a respiracao e meios para realizar o metodo e o diagnostico
KR950701820A (ko) 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
ATE360428T1 (de) Analgetisches arzneimittel
BR9813641A (pt) &#34;preparados transmucosais de levosimendan&#34;
PT859613E (pt) Utilizacao de flupirtina para a profilaxia e o tratamento de doencas associadas a uma alteracao do sistema celular hematopoietico
MY124071A (en) Treatment of viral disease in swine
FR2572286B1 (fr) Utilisation du 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamide pour le traitement de maladies virales chez l&#39;homme
PT740657E (pt) 4-aril-isoindois com actividade analgesica
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
PT100284A (pt) Anti-helmintico de benzimidazol para uso no fabrico de um medicamento para o tratamento de infeccao microsporideos
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
NO951608D0 (no) Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon
DK1143976T3 (da) Beta-D-2&#39;, 3&#39;-didehydro-2&#39;, 3&#39;-dideoxy-5-fluorcytidin til anvendelse i behandlingen af HIV-infektioner
HUP0100879A2 (hu) Nukleozidok és alkalmazásuk vírusellenes gyógyszerkészítmények előállítására
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
ATE112489T1 (de) Extrakte von acanthospermum hispidum-pflanzen.
DE69634536D1 (de) 2,4-dichlorbenzylalkohol und amylmetakresol gegen hiv-infektion
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]